Diagnostics,
Год журнала:
2023,
Номер
13(21), С. 3359 - 3359
Опубликована: Ноя. 1, 2023
Lung
cancer
is
the
leading
cause
of
deaths
in
men
and
women
United
States.
Accurate
staging
needed
to
determine
prognosis
devise
effective
treatment
plans.
The
International
Association
for
Study
Cancer
(IASLC)
has
made
multiple
revisions
tumor,
node,
metastasis
(TNM)
system
used
by
Union
Control
American
Joint
Committee
on
stage
lung
cancer.
eighth
edition
this
includes
modifications
T
classification
with
cut
points
1
cm
increments
tumor
size,
grouping
cancers
associated
partial
or
complete
atelectasis
pneumonitis,
tumors
involvement
a
main
bronchus
regardless
distance
from
carina,
upstaging
diaphragmatic
invasion
T4.
N
describes
spread
regional
lymph
nodes
no
changes
were
proposed
TNM-8.
In
M
classification,
metastatic
disease
divided
into
intra-
versus
extrathoracic
metastasis,
single
metastases.
order
optimize
patient
outcomes,
it
important
understand
nuances
TNM
system,
strengths
weaknesses
various
imaging
modalities
staging,
potential
pitfalls
image
interpretation.
Quantitative Imaging in Medicine and Surgery,
Год журнала:
2024,
Номер
14(8), С. 5460 - 5472
Опубликована: Фев. 23, 2024
Non-small
cell
lung
cancer
(NSCLC)
patients
with
epidermal
growth
factor
receptor-sensitizing
(EGFR-sensitizing)
mutations
exhibit
a
positive
response
to
tyrosine
kinase
inhibitors
(TKIs).
Given
the
limitations
of
current
clinical
predictive
methods,
it
is
critical
explore
radiomics-based
approaches.
In
this
study,
we
leveraged
deep-learning
technology
multimodal
radiomics
data
more
accurately
predict
EGFR-sensitizing
mutations.
Seminars in Nuclear Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 1, 2025
Lung
cancer
remains
one
of
the
most
prevalent
cancers
globally
and
leading
cause
cancer-related
deaths,
accounting
for
nearly
one-fifth
all
fatalities.
Fluoro-2-deoxy-D-glucose
positron
emission
tomography/computed
tomography
([18F]FDG
PET/CT)
plays
a
vital
role
in
assessing
lung
managing
disease
progression.
While
traditional
PET/CT
imaging
relies
on
qualitative
analysis
basic
quantitative
parameters,
radiomics
offers
more
advanced
approach
to
analyzing
tumor
phenotypes.
Recently,
has
gained
attention
its
potential
enhance
prognostic
diagnostic
capabilities
[18F]FDG
various
cancers.
This
review
explores
expanding
PET/CT-based
radiomics,
particularly
when
integrated
with
artificial
intelligence
(AI),
cancer,
especially
non-small
cell
(NSCLC).
We
how
AI
improve
diagnostics,
staging,
subtype
identification,
molecular
marker
detection,
which
influence
treatment
decisions.
Additionally,
we
address
challenges
clinical
integration,
such
as
protocol
standardization,
feature
reproducibility,
need
extensive
prospective
studies.
Ultimately,
hold
great
promise
enabling
personalized
effective
treatments,
potentially
transforming
management.
Nuclear Medicine Communications,
Год журнала:
2025,
Номер
46(4), С. 326 - 336
Опубликована: Янв. 20, 2025
Prediction
of
epidermal
growth
factor
receptor
(EGFR)
mutation
status
and
subtypes
in
patients
with
non-small
cell
lung
cancer
(NSCLC)
based
on
18
F-fluorodeoxyglucose
(
F-FDG)
PET/computed
tomography
(CT)
radiomics
features.
Retrospective
analysis
201
NSCLC
F-FDG
PET/CT
EGFR
genetic
testing
was
carried
out.
Radiomics
features
clinical
factors
were
used
to
construct
a
combined
model
for
identifying
status.
Mutation/wild-type
models
trained
training
cohort
n
=
129)
validated
an
internal
validation
41)
vs
external
50).
A
second
predicting
the
19/21
locus
also
built
evaluated
subset
mutations
(training
cohort,
55;
14).
The
predictive
performance
net
benefit
assessed
by
area
under
curve
(AUC)
subjects,
nomogram,
calibration
decision
curve.
AUC
distinguishing
0.864
0.806
0.791
test
sets
respectively,
site
0.971
0.867
respectively.
curves
individual
showed
better
predictions
(Brier
score
<0.25).
Decision
that
had
application.
can
predict
patients,
guiding
targeted
therapy,
facilitate
precision
medicine
development.
Scientific Reports,
Год журнала:
2022,
Номер
12(1)
Опубликована: Сен. 1, 2022
We
aimed
to
construct
a
prediction
model
based
on
computed
tomography
(CT)
radiomics
features
classify
COVID-19
patients
into
severe-,
moderate-,
mild-,
and
non-pneumonic.
A
total
of
1110
were
studied
from
publicly
available
dataset
with
4-class
severity
scoring
performed
by
radiologist
(based
CT
images
clinical
features).
The
entire
lungs
segmented
followed
resizing,
bin
discretization
radiomic
extraction.
utilized
two
feature
selection
algorithms,
namely
bagging
random
forest
(BRF)
multivariate
adaptive
regression
splines
(MARS),
each
coupled
classifier,
multinomial
logistic
(MLR),
multiclass
classification
models.
was
divided
50%
(555
samples),
20%
(223
30%
(332
samples)
for
training,
validation,
untouched
test
datasets,
respectively.
Subsequently,
nested
cross-validation
train/validation
select
the
tune
All
predictive
power
indices
reported
testing
set.
performance
multi-class
models
assessed
using
precision,
recall,
F1-score,
accuracy
4
×
confusion
matrices.
In
addition,
areas
under
receiver
operating
characteristic
curves
(AUCs)
classifications
calculated
compared
both
Using
BRF,
23
selected,
11
first-order,
9
GLCM,
1
GLRLM,
GLDM,
shape.
Ten
selected
MARS
algorithm,
3
GLSZM,
shape,
GLCM
features.
mean
absolute
deviation,
skewness,
variance
first-order
flatness
cluster
prominence
Gray
Level
Non
Uniformity
Normalize
GLRLM
BRF
algorithms.
or
significantly
associated
four-class
outcomes
as
within
MLR
(All
p
values
<
0.05).
+
resulted
in
pseudo-R
Journal of Digital Imaging,
Год журнала:
2022,
Номер
36(2), С. 497 - 509
Опубликована: Ноя. 14, 2022
Abstract
A
U-shaped
contraction
pattern
was
shown
to
be
associated
with
a
better
Cardiac
resynchronization
therapy
(CRT)
response.
The
main
goal
of
this
study
is
automatically
recognize
left
ventricular
contractile
patterns
using
machine
learning
algorithms
trained
on
conventional
quantitative
features
(ConQuaFea)
and
radiomic
extracted
from
Gated
single-photon
emission
computed
tomography
myocardial
perfusion
imaging
(GSPECT
MPI).
Among
98
patients
standard
resting
GSPECT
MPI
included
in
study,
29
received
CRT
69
did
not
(also
had
inclusion
criteria
but
receive
treatment
yet
at
the
time
data
collection,
or
refused
treatment).
total
non-CRT
were
employed
for
training,
testing.
models
built
utilizing
three
distinct
feature
sets
(ConQuaFea,
radiomics,
ConQuaFea
+
radiomics
(combined)),
which
chosen
Recursive
elimination
(RFE)
selection
(FS),
then
seven
different
(ML)
classifiers.
In
addition,
outcome
prediction
assessed
by
as
study’s
final
phase.
MLP
classifier
highest
performance
among
(AUC,
SEN,
SPE
=
0.80,
0.85,
0.76).
RF
achieved
best
terms
AUC,
values
0.65,
0.62,
0.68,
respectively,
models.
GB
approaches
0.78,
0.92,
0.63
0.74,
0.93,
0.56,
combined
promising
obtained
when
detect
learning.
La radiologia medica,
Год журнала:
2023,
Номер
128(12), С. 1521 - 1534
Опубликована: Сен. 26, 2023
Abstract
Purpose
Glioblastoma
Multiforme
(GBM)
represents
the
predominant
aggressive
primary
tumor
of
brain
with
short
overall
survival
(OS)
time.
We
aim
to
assess
potential
radiomic
features
in
predicting
time-to-event
OS
patients
GBM
using
machine
learning
(ML)
algorithms.
Materials
and
methods
One
hundred
nineteen
GBM,
who
had
T1-weighted
contrast-enhanced
T2-FLAIR
MRI
sequences,
along
clinical
data
time,
were
enrolled.
Image
preprocessing
included
64
bin
discretization,
Laplacian
Gaussian
(LOG)
filters
three
Sigma
values
eight
variations
Wavelet
Transform.
Images
then
segmented,
followed
by
extraction
1212
features.
Seven
feature
selection
(FS)
six
ML
algorithms
utilized.
The
combination
preprocessing,
FS,
(12
×
7
6
=
504
models)
was
evaluated
multivariate
analysis.
Results
Our
analysis
showed
that
best
prognostic
FS/ML
combinations
are
Mutual
Information
(MI)/Cox
Boost,
MI/Generalized
Linear
Model
Boosting
(GLMB)
Network
(GLMN),
all
which
done
via
LOG
(Sigma
1
mm)
method
(C-index
0.77).
filter
mm
method,
MI,
GLMB
GLMN
achieved
significantly
higher
C-indices
than
other
(all
p
<
0.05,
mean
0.65,
0.70,
0.64,
respectively).
Conclusion
capable
MRI-based
radiomics
variables
might
appear
promising
assisting
clinicians
prediction
GBM.
Further
research
is
needed
establish
applicability
management
clinic.
Biomedicines,
Год журнала:
2024,
Номер
12(3), С. 472 - 472
Опубликована: Фев. 20, 2024
The
aim
of
our
study
was
to
predict
the
occurrence
distant
metastases
in
non-small-cell
lung
cancer
(NSCLC)
patients
using
machine
learning
methods
and
texture
analysis
18F-labeled
2-deoxy-d-glucose
Positron
Emission
Tomography/Computed
Tomography
{[18F]FDG
PET/CT}
images.
In
this
retrospective
single-center
study,
we
evaluated
79
with
advanced
NSCLC
who
had
undergone
[18F]FDG
PET/CT
scan
at
diagnosis
before
any
therapy.
Patients
were
divided
into
two
independent
training
(n
=
44)
final
testing
35)
cohorts.
Texture
features
primary
tumors
lymph
node
extracted
from
images
LIFEx
program.
Six
applied
dataset
entire
panel
features.
Dedicated
selection
used
generate
different
combinations
five
performance
selected
determined
accuracy,
confusion
matrix,
receiver
operating
characteristic
(ROC)
curves,
area
under
curve
(AUC).
A
total
104
78
lesions
analyzed
cohorts,
respectively.
support
vector
(SVM)
decision
tree
showed
highest
accuracy
cohort.
Seven
obtained
introduced
models
subsequently
cohorts
SVM
tree.
AUC
method
higher
than
those
best
combination
included
shape
sphericity,
gray
level
run
length
matrix_run
non-uniformity
(GLRLM_RLNU),
Total
Lesion
Glycolysis
(TLG),
Metabolic
Tumor
Volume
(MTV),
compacity.
these
could
an
74.4%
0.63
patients.
Cancers,
Год журнала:
2025,
Номер
17(5), С. 882 - 882
Опубликована: Март 4, 2025
According
to
data
from
the
World
Health
Organization
(WHO),
lung
cancer
is
becoming
a
global
epidemic.
It
particularly
high
in
list
of
leading
causes
death
not
only
developed
countries,
but
also
worldwide;
furthermore,
it
holds
place
terms
cancer-related
mortality.
Nevertheless,
many
breakthroughs
have
been
made
last
two
decades
regarding
its
management,
with
one
most
prominent
being
implementation
artificial
intelligence
(AI)
various
aspects
disease
management.
We
included
473
papers
this
thorough
review,
which
published
during
5-10
years,
order
describe
these
breakthroughs.
In
screening
programs,
AI
capable
detecting
suspicious
nodules
different
imaging
modalities-such
as
chest
X-rays,
computed
tomography
(CT),
and
positron
emission
(PET)
scans-but
discriminating
between
benign
malignant
well,
success
rates
comparable
or
even
better
than
those
experienced
radiologists.
Furthermore,
seems
be
able
recognize
biomarkers
that
appear
patients
who
may
develop
cancer,
years
before
event.
Moreover,
can
assist
pathologists
cytologists
recognizing
type
tumor,
well
specific
histologic
genetic
markers
play
key
role
treating
disease.
Finally,
treatment
field,
guide
development
personalized
options
for
patients,
possibly
improving
their
prognosis.
Seminars in Nuclear Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 1, 2025
The
advent
of
sophisticated
image
analysis
techniques
has
facilitated
the
extraction
increasingly
complex
data,
such
as
radiomic
features,
from
various
imaging
modalities,
including
[18F]FDG
PET/CT,
a
well-established
cornerstone
oncological
imaging.
Furthermore,
use
artificial
intelligence
(AI)
algorithms
shown
considerable
promise
in
enhancing
interpretation
these
quantitative
parameters.
Additionally,
AI-driven
models
enable
integration
parameters
multiple
modalities
along
with
clinical
facilitating
development
comprehensive
significant
impact.
However,
challenges
remain
regarding
standardization
and
validation
AI-powered
models,
well
their
implementation
real-world
practice.
variability
acquisition
protocols,
segmentation
methods,
feature
approaches
across
different
institutions
necessitates
robust
harmonization
efforts
to
ensure
reproducibility
utility.
Moreover,
successful
translation
AI
into
practice
requires
prospective
large
cohorts,
seamless
existing
workflows
assess
ability
enhance
clinicians'
performance.
This
review
aims
provide
an
overview
literature
highlight
three
key
applications:
diagnostic
impact,
prediction
treatment
response,
long-term
patient
prognostication.
In
first
part,
we
will
focus
on
head
neck,
lung,
breast,
gastroesophageal,
colorectal,
gynecological
malignancies.